This video takes a look at what's next for Arena Pharmaceuticals and the rest of the obesity drug makers. With the first approved weight-loss drug in more than a decade, Arena is in the driver's seat, but success is not guaranteed.
Obesity drugs aren't the only huge story in health care right now. Even though the Supreme Court ruled the ACA is constitutional, that doesn't mean the health-reform fight is over. The 2012 elections loom large, but the Fool has you covered with our new special free report "These Stocks Could Skyrocket After the 2012 Presidential Election," where you'll get ideas for companies in health care and beyond that can benefit from each candidate's platform. Get your free copy.
The article What's Next for Arena? originally appeared on Fool.com.
David Williamsonholds no position in any company mentioned. Check out hisholdings and a short bio. We Fools don't all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. Try any of our Foolish newsletter servicesfree for 30 days. The Motley Fool has adisclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.